Post COVID-19 Infection with Staphylococcus Aureus Bacteraemia: A Case Series

Staphylococcus aureus (S.aureus) is a leading bacterial pathogen, that causes deadly infections such as bacteraemia, Toxic Shock Syndrome (TSS) and endocarditis. It has been the main contributor to secondary bacterial infections during viral pandemics, greatly raising patient morbidity and fatality...

Full description

Bibliographic Details
Main Authors: Meruva Karthik, Alekhya Abburu, Kainat Aftab
Format: Article
Language:English
Published: JCDR Research and Publications Private Limited 2023-05-01
Series:Journal of Clinical and Diagnostic Research
Subjects:
Online Access:https://jcdr.net/articles/PDF/17962/61840_CE[Ra1]_F(IS)_PF1(HB_KM)_PN(KM).pdf
_version_ 1797815444282802176
author Meruva Karthik
Alekhya Abburu
Kainat Aftab
author_facet Meruva Karthik
Alekhya Abburu
Kainat Aftab
author_sort Meruva Karthik
collection DOAJ
description Staphylococcus aureus (S.aureus) is a leading bacterial pathogen, that causes deadly infections such as bacteraemia, Toxic Shock Syndrome (TSS) and endocarditis. It has been the main contributor to secondary bacterial infections during viral pandemics, greatly raising patient morbidity and fatality rates. It is unknown how this secondary bacteraemia would affect people who have Severe Acute Respiratory Distress Syndrome Coronavirus 2 (SARS-CoV2). Herein, the authors present a series of case studies of 8 patients, (4 males and 4 females) infected with Coronavirus Disease-2019 (COVID-19) at tertiary hospital, Hyderabad, India, who eventually developed S.aureus bacteraemia with widespread seeding of secondary infections including cellulitis and abscess formation. Adult patients aged 20-60 years of age who were infected with COVID-19 from June’2022-August’2022 and had positive bacterial cultures for S.aureus during admission were included in the study. A total of eight patients hospitalised for COVID-19 with secondary bacteraemia were identified. Of these patients admitted with severe limb infections, three patients expired after a week of ongoing treatment from their blood cultures. Multivariate analysis identified the onset of bacteraemia (>4 days from date of admission) and age as significant predictors of mortality in admitted patients. Systemic Inflammatory Response Syndrome (SIRS) scoring and blood cultures were used to identify the mortality risk with p-value=0.05 statistical significance. The patients were subsequently treated with antibiotics and given conservative management, some of the patients admitted to Intensive Care Unit (ICU) who had critical co-morbidities, expired within a week of ongoing treatment. The final outcome of the present case series was that bacteraemia caused by S.aureus is associated with a high mortality rate in COVID-19 patients. More research is needed to understand the relationship between COVID-19 and secondary S.aureus bacteraemia.
first_indexed 2024-03-13T08:22:47Z
format Article
id doaj.art-8d1e471c51e34569ae7efa5a2f4f30ce
institution Directory Open Access Journal
issn 2249-782X
0973-709X
language English
last_indexed 2024-03-13T08:22:47Z
publishDate 2023-05-01
publisher JCDR Research and Publications Private Limited
record_format Article
series Journal of Clinical and Diagnostic Research
spelling doaj.art-8d1e471c51e34569ae7efa5a2f4f30ce2023-05-31T05:52:07ZengJCDR Research and Publications Private LimitedJournal of Clinical and Diagnostic Research2249-782X0973-709X2023-05-01175OR01OR0410.7860/JCDR/2023/61840.17962Post COVID-19 Infection with Staphylococcus Aureus Bacteraemia: A Case SeriesMeruva Karthik0Alekhya Abburu1Kainat Aftab2Assistant Professor, Department of Internal Medicine, Kamineni Academy of Medical Sciences, Hyderabad, Telangana, India.Postgraduate Intern, Department of Internal Medicine, Kamineni Academy of Medical Sciences, Hyderabad, Telangana, India.Postgraduate Intern, Department of Internal Medicine, Kamineni Academy of Medical Sciences, Hyderabad, Telangana, India.Staphylococcus aureus (S.aureus) is a leading bacterial pathogen, that causes deadly infections such as bacteraemia, Toxic Shock Syndrome (TSS) and endocarditis. It has been the main contributor to secondary bacterial infections during viral pandemics, greatly raising patient morbidity and fatality rates. It is unknown how this secondary bacteraemia would affect people who have Severe Acute Respiratory Distress Syndrome Coronavirus 2 (SARS-CoV2). Herein, the authors present a series of case studies of 8 patients, (4 males and 4 females) infected with Coronavirus Disease-2019 (COVID-19) at tertiary hospital, Hyderabad, India, who eventually developed S.aureus bacteraemia with widespread seeding of secondary infections including cellulitis and abscess formation. Adult patients aged 20-60 years of age who were infected with COVID-19 from June’2022-August’2022 and had positive bacterial cultures for S.aureus during admission were included in the study. A total of eight patients hospitalised for COVID-19 with secondary bacteraemia were identified. Of these patients admitted with severe limb infections, three patients expired after a week of ongoing treatment from their blood cultures. Multivariate analysis identified the onset of bacteraemia (>4 days from date of admission) and age as significant predictors of mortality in admitted patients. Systemic Inflammatory Response Syndrome (SIRS) scoring and blood cultures were used to identify the mortality risk with p-value=0.05 statistical significance. The patients were subsequently treated with antibiotics and given conservative management, some of the patients admitted to Intensive Care Unit (ICU) who had critical co-morbidities, expired within a week of ongoing treatment. The final outcome of the present case series was that bacteraemia caused by S.aureus is associated with a high mortality rate in COVID-19 patients. More research is needed to understand the relationship between COVID-19 and secondary S.aureus bacteraemia.https://jcdr.net/articles/PDF/17962/61840_CE[Ra1]_F(IS)_PF1(HB_KM)_PN(KM).pdfcoronavirus disease-2019severe acute respiratory distress syndrome coronavirus 2systemic inflammatory response syndrome
spellingShingle Meruva Karthik
Alekhya Abburu
Kainat Aftab
Post COVID-19 Infection with Staphylococcus Aureus Bacteraemia: A Case Series
Journal of Clinical and Diagnostic Research
coronavirus disease-2019
severe acute respiratory distress syndrome coronavirus 2
systemic inflammatory response syndrome
title Post COVID-19 Infection with Staphylococcus Aureus Bacteraemia: A Case Series
title_full Post COVID-19 Infection with Staphylococcus Aureus Bacteraemia: A Case Series
title_fullStr Post COVID-19 Infection with Staphylococcus Aureus Bacteraemia: A Case Series
title_full_unstemmed Post COVID-19 Infection with Staphylococcus Aureus Bacteraemia: A Case Series
title_short Post COVID-19 Infection with Staphylococcus Aureus Bacteraemia: A Case Series
title_sort post covid 19 infection with staphylococcus aureus bacteraemia a case series
topic coronavirus disease-2019
severe acute respiratory distress syndrome coronavirus 2
systemic inflammatory response syndrome
url https://jcdr.net/articles/PDF/17962/61840_CE[Ra1]_F(IS)_PF1(HB_KM)_PN(KM).pdf
work_keys_str_mv AT meruvakarthik postcovid19infectionwithstaphylococcusaureusbacteraemiaacaseseries
AT alekhyaabburu postcovid19infectionwithstaphylococcusaureusbacteraemiaacaseseries
AT kainataftab postcovid19infectionwithstaphylococcusaureusbacteraemiaacaseseries